SMPD2 and inflammatory bowel disease: A previous study observed that probiotic bacteria in a mouse IBD model produced a neutral sphingomyelinase that could convert sphingomyelin into ceramides, promoting apoptosis of mucosal immune cells leading to improved homeostasis and reduced inflammation [24].